article thumbnail

What the Law and Bioethics Tell Us About Synthetic Human Embryos

Bill of Health

There is no specific regulation governing such research in the U.S.; it’s just that the federal government won’t fund the research. The post What the Law and Bioethics Tell Us About Synthetic Human Embryos first appeared on Bill of Health. To date, most, if not all, U.S. The original article can be found here.

Bioethics 298
article thumbnail

A Human Rights Approach to Personal Information Technology

Bill of Health

Either way, the ability to freely choose one’s partner or licensed fiduciary is a core human right. Decentralized cooperative finance enables more diverse and resilient alternatives to corporate or government control of our essential infrastructure. This avoids vendor lock-in to corporate or government interests.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

Such a provision could prevent the public from paying twice for publicly-funded medical products—first through their taxes subsidizing government funded research and development, and second to procure the product in an inflated U.S. pharmaceutical market. Moreover, the NASDAQ Biotechnology Index increased by 374% from 1995 to 2000.

COVID-19 205
article thumbnail

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Health Populi

When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 government. (In a pill to $750 a pill. Shkreli was ultimately convicted on securities fraud (not related to the Draprim pricing strategy). In total, U.S.